Abstract

BackgroundMicroRNAs (miRNAs) have been shown to be associated with osteoarthritis (OA) progression. This study aimed to explore the role of miR-520c-3p in OA progression.MethodsExpression levels of miR-520c-3p and Growth arrest-specific 2 (GAS2) were detected using quantitative real-time PCR. The proliferation and apoptosis of cells were measured using cell counting kit 8 (CCK8) assay and flow cytometry. Furthermore, the protein levels of apoptosis-related markers, extracellular degradation markers, inflammatory response markers, and GAS2 were tested using quantitative real-time polymerase chain reaction (RT-PCR) and western blot (WB) analysis. In addition, the interaction between miR-520c-3p and GAS2 was examined using dual luciferase reporter assay.ResultsGAS2 was highly expressed, and miR-520c-3p was lowly expressed in OA cartilage tissues. miR-520c-3p could promote the proliferation and inhibit the apoptosis and inflammation of OA chondrocytes. miR-520c-3p could be sponged by GAS2, and its inhibitor could reverse the regulation of GAS2 on the biological functions of OA chondrocytes. GAS2 was a target of miR-520c-3p, which was identified by bioinformatic analysis and dual-luciferase reporter assay. Overexpression of GAS2 could inhibit the proliferation and promoted the apoptosis and inflammation of OA chondrocytes.ConclusionOur data showed that miR-520c-3p might regulate the GAS2 to inhibit the progression of OA.

Highlights

  • IntroductionMicroRNAs (miRNAs) have been shown to be associated with osteoarthritis (OA) progression

  • MicroRNAs have been shown to be associated with osteoarthritis (OA) progression

  • We found that the overexpression of Growth arrest-specific 2 (GAS2) was able to reverse the protective effect of miR520c-3p on Interleukin 1 beta (IL-1β)-induced chondrocyte apoptosis

Read more

Summary

Introduction

MicroRNAs (miRNAs) have been shown to be associated with osteoarthritis (OA) progression. This study aimed to explore the role of miR-520c-3p in OA progression. Osteoarthritis (OA) is degenerative disease and is a major cause of pain and physical disability [1]. 15% of the global population suffer from OA [2]. Genetics, aging, obesity, and mechanical stress are the primary causes of OA [3]. Clinical therapy for OA includes nonsteroidal anti-inflammatory drugs (NSAIDs), platelet-rich plasma (PRP), or hyaluronic acid (HA) injections [4, 5]. There are numerous factors involved in the development of OA, IL-1β has been reported to play a dominant role in the pathogenesis of OA. IL-1β can significantly increase cartilage damage and used to mimic OA in vitro studies [9].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call